Download App
PAPER TRADE
Download App
Login
Feedback
SUNPHARMA
newsbot
Reputation: 200,090 •
Aug 10, 2020 2:53 AM
Buy Sun Pharmaceuticals; target of Rs 571: Dolat Capital
Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 571 in its research report dated August 01, 2020.
Moneycontrol
https://www.moneycontrol.com/news/business/stocks/buy-sun...
#SUNPHARMA
Vote
Comment
Share
NSE:SUNPHARMA price when posted: 525.85